Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Dirección de esta página: https://medlineplus.gov/spanish/druginfo/natural/901.html

Comino Negro

¿Qué es?

El comino negro (Nigella sativa) es una planta con flores originaria de Asia y el Mediterráneo. Su semilla se ha utilizado para fabricar medicamentos durante miles de años.

El comino negro puede tener efectos en el cuerpo que ayudan a estimular el sistema inmunológico, combatir el cáncer, prevenir el embarazo, reducir la hinchazón y disminuir las reacciones alérgicas al actuar como antihistamínico.

Las personas comúnmente usan comino negro para el asma, la fiebre del heno, la diabetes, la presión arterial alta, el eccema, la pérdida de peso, los calambres menstruales y muchas otras condiciones, pero no existe una buena evidencia científica que respalde muchos de estos usos. Tampoco hay buena evidencia que respalde el uso de comino negro para COVID-19.

¿Qué tan efectivo es?

Natural Medicines Comprehensive Database (La Base Exhaustiva de Datos de Medicamentos Naturales) clasifica la eficacia, basada en evidencia científica, de acuerdo a la siguiente escala: Eficaz, Probablemente Eficaz, Posiblemente Eficaz, Posiblemente Ineficaz, Probablemente Ineficaz, Ineficaz, e Insuficiente Evidencia para Hacer una Determinación.

La clasificación de la eficacia para este producto es la siguiente:

Posiblemente eficaz para...

  • Acné. La aplicación de un gel que contenga extracto de comino negro sobre la piel podría ayudar a mejorar el acné.
  • Fiebre del heno. La ingesta diaria de aceite de comino negro podría mejorar los síntomas de alergia en personas con fiebre del heno.
  • Asma. La ingesta de comino negro junto con medicamentos para el asma puede mejorar la tos, las sibilancias y la función pulmonar en algunas personas con asma. Pero parece funcionar solo en personas con una función pulmonar muy baja antes del tratamiento.
  • Una enfermedad pulmonar que dificulta la respiración (enfermedad pulmonar obstructiva crónica o EPOC). La ingesta de aceite de semilla negra ayuda a mejorar la función pulmonar en personas con EPOC que también usan inhaladores recetados.
  • Diabetes. La ingesta diaria de polvo de comino negro o aceite de comino negro parece mejorar los niveles de azúcar en sangre en personas con diabetes.
  • Una infección del tracto digestivo que puede provocar úlceras (Helicobacter pylori o H. pylori). La ingesta de polvo de comino negro junto con las terapias estándar podría ayudar a deshacerse de esta infección.
  • Alta presión sanguínea. La ingesta de polvo de comino negro o aceite de comino negro puede reducir la presión arterial en una pequeña cantidad en adultos sanos. Pero no está claro si ayuda a las personas con presión arterial alta.
  • Condiciones en un hombre que le impiden embarazar a una mujer dentro de un año de intentar concebir (infertilidad masculina). La ingesta de aceite de comino negro aumenta el recuento de espermatozoides y la rapidez con que se mueven los espermatozoides. No está claro si mejora las tasas de embarazo.
  • Dolor de seno (mastalgia). La aplicación de un gel que contiene aceite de comino negro en los senos durante el ciclo menstrual parece reducir el dolor.
Existe interés en usar comino negro para otros propósitos, pero no hay suficiente información confiable para decir si podría ser útil.

¿Es seguro?

Cuando se toma por vía oral: El comino negro se consume comúnmente en los alimentos. El aceite de comino negro y el polvo de comino negro son posiblemente seguros cuando se toman en grandes cantidades por hasta 3 meses. No hay suficiente información confiable para saber si cantidades mayores son seguras cuando se usan durante más de 3 meses. El comino negro puede causar erupciones alérgicas en algunas personas. También puede causar malestar estomacal, vómitos o estreñimiento.

Cuando se aplica a la piel: El aceite o gel de comino negro es posiblemente seguro cuando se usa a corto plazo. Puede causar erupciones alérgicas en algunas personas.

Advertencias y precauciones especiales:

Embarazo: El comino negro se consume comúnmente en los alimentos. Pero tomar cantidades mayores a las que se encuentran en los alimentos durante el embarazo probablemente no sea seguro. El comino negro puede ralentizar o detener la contracción del útero.

Lactancia: No hay suficiente información confiable para saber si el comino negro es segura de usar durante la lactancia. Manténgase en el lado seguro y evite su uso.

Niños: El aceite de comino negro es posiblemente seguro para los niños cuando se ingiere por vía oral a corto plazo y en las cantidades recomendadas por peso.

Trastornos hemorrágicos: El comino negro puede retardar la coagulación sanguínea y aumentar el riesgo de hemorragia. El comino negro podría empeorar los trastornos hemorrágicos.

Cirugía: El comino negro puede retardar la coagulación de la sangre, reducir el azúcar en la sangre y aumentar la somnolencia en algunas personas. Esto puede interferir con los medicamentos que se usan durante y después de los procedimientos quirúrgicos y causar efectos secundarios graves. Deje de usar comino negro al menos dos semanas antes de una cirugía programada.

¿Existen interacciones con medicamentos?

Moderadas
Tenga cuidado con esta combinación
Amlodipina (Norvasc)
La almopidina (Norvasc) reduce la presión arterial. El comino negro también reduce la presion arterial. Tomar comino negro con amlodipina podría reducir demasiado la presión arterial. Las personas que toman comino negro junto con amlodipina deben controlar su presión arterial.
Ciclosporina (Neoral, Sandimmune)
El comino negro podría disminuir los niveles de ciclosporina en la sangre. Esto podría reducir la eficacia de la ciclosporina.
Clopidogrel (Plavix)
El clopidogrel puede retrasar la coagulación de la sangre. El comino negro también podría retardar la coagulación de la sangre. Tomar comino negro junto con clopidogrel podría aumentar las posibilidades de hematomas y sangrado.
Fenitoína (Dilantin)
La fenitoína se usa para controlar algunos tipos de convulsiones. El comino negro podría aumentar o reducir los niveles de fenitoína en la sangre. Tomar comino negro con fenitoína podría reducir los efectos o aumentar el riesgo de tener efectos secundarios a la fenitoína.
Medicamentos modificados por el hígado (sustratos del citocromo P450 2C9 (CYP2C9))
El hígado cambia y descompone algunos medicamentos. El comino negro podría cambiar la rapidez con la que el hígado descompone estos medicamentos. Esto podría cambiar los efectos y efectos secundarios de estos medicamentos.
Medicamentos para la diabetes (Antidiabéticos)
El comino negro podría disminuir los niveles de azúcar en la sangre en algunas personas. Los medicamentos para la diabetes también se usan para disminuir los niveles de azúcar en la sangre. La ingesta de comino negro junto con medicamentos para la diabetes podría causar una marcada disminución de los niveles de azúcar en la sangre. Controle minuciosamente sus niveles de azúcar en sangre. Podría necesitar modificar la dosis de su medicamento para la diabetes.

Algunos medicamentos usados para la diabetes incluyen glimepirida (Amaryl), gliburida (Diabeta, Glynase, PresTab, Micronase), insulina, metformina (Glucophage), pioglitazona (Actos), rosiglitazona (Avandia) y otros.
Medicamentos que debilitan el sistema inmunitario (Inmunosupresores)
El comino negro podría aumentar el sistema inmunitario. Al estimular el sistema inmunitario, el comino negro podría disminuir la efectividad de los medicamentos que debilitan el sistema inmunitario.

Estos medicamentos que debilitan el sistema inmunitario incluyen azatioprina (Imuran), basiliximab (Simulect), ciclosporina (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), micofenolato (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisona (Deltasone, Orasone), corticoesteroides (glucocorticoides) y otros.
Medicamentos que debilitan el sistema inmunitario (medicamentos serotoninérgicos)
El comino negro podría elevar los niveles de una sustancia química llamada serotonina. Ciertos medicamentos también podían aumentar los niveles de serotonina en el cerebro. La ingesta de comino negro junto con estos medicamentos podría causar un marcado aumento de los niveles de serotonina. Esto podría derivar en efectos secundarios graves, como cefaleas fuertes, problemas cardíacos, escalofríos, confusión y ansiedad.

Algunos de estos medicamentos incluyen fluoxetina (Prozac), paroxetina (Paxil), sertralina (Zoloft), amitriptilina (Elavil), clomipramina (Anafranil), imipramina (Tofranil), sumatriptano (Imitrex), zolmitriptano (Zomig), rizatriptano (Maxalt), metadona (Dolophine), tramadol (Ultram) y otros.
Medicamentos que disminuyen la coagulación de la sangre (Anticoagulantes / Antiplaquetarios)
El comino negro podría disminuir la coagulación de la sangre. La ingesta de comino negro junto con otros medicamentos que también disminuyen la coagulación podría incrementar la probabilidad de sufrir hematomas y hemorragia.

Algunos medicamentos que disminuyen la coagulación de la sangre incluyen aspirina, pidogrel (Plavix), medicamentos antinflamatorios no esteroides (AINE), tales como diclofenac (Voltaren, Cataflam, entre otros), ibuprofeno (Advil, Motrin y otros), naproxeno (Anaprox, Naprosyn y otros), dalteparina (Fragmin), enoxaparina (Lovenox), heparina, warfarina (Coumadin), entre otros otros.
Medicamentos sedantes (depresores del SNC)
El comino negro podría causar adormecimiento y somnolencia. Los medicamentos que causan adormecimiento se denominan sedantes. La ingesta comino negro junto con sedantes podría causar demasiada somnolencia.

Ciertos sedantes incluyen clonazepam (Klonopin), lorazepam (Ativan), fenobarbital (Donnatal) y zolpidem (Ambien) entre otros.
Medicamentos usados para la presión arterial alta (medicamentos antihipertensivos)
El comino negro podría disminuir la presión arterial en algunas personas. La ingesta de comino negro junto con medicamentos usados para la diabetes podría causar una marcada disminución de los niveles de azúcar en la sangre. No ingerir demasiado comino negro si ingiere medicamentos para la presión arterial alta.

Ciertos medicamentos para la presión arterial alta incluyen la nifedipina (Adalat, Procardia), verapamil (Calan, Isoptin,Verelan), diltiazem (Cardizem), isradipina (DynaCirc), felodipina (Plendil) y amlodipina (Norvasc) entre otros.
Pastillas de agua (Drogas diuréticas)
El comino negro puede disminuir los niveles de potasio. Las "pastillas de agua" también pueden disminuir los niveles de potasio. Tomar comino negro junto con "pastillas de agua" puede hacer que los niveles de potasio bajen demasiado.
Sildenafil (Viagra)
El comino negro podría reducir los niveles de sildenafil en el cuerpo. Tomar comino negro con sildenafil podría reducir los efectos del sildenafil.
Warfarina (Coumadin)
La warfarina se usa para retardar la coagulación de la sangre. El comino negro podría aumentar los efectos de la warfarina, lo que podría aumentar el riesgo de sangrado.

¿Existen interacciones con hierbas y suplementos?

Hierbas y suplementos con propiedades sedantes
El comino negro puede causar somnolencia y respiración lenta. Tomarlo junto con otros suplementos con efectos similares puede causar demasiada somnolencia y / o respiración lenta en algunas personas. Ejemplos de suplementos con este efecto incluyen lúpulo, kava, L-triptófano, melatonina y valeriana.
Hierbas y suplementos con propiedades serotoninérgicas
El comino negro aumenta una sustancia química del cerebro llamada serotonina. Tomarlo junto con otros suplementos que tienen este efecto puede causar efectos secundarios graves, incluidos problemas cardíacos, convulsiones y vómitos. Ejemplos de suplementos con este efecto incluyen 5-HTP, L-triptófano, SAMe y la hierba de San Juan.
Hierbas y suplementos que pueden reducir el azúcar en sangre
El comino negro podría reducir el azúcar en sangre. Tomarlo con otros suplementos con efectos similares podría reducir demasiado el azúcar en sangre. Ejemplos de suplementos con este efecto incluyen aloe, melón amargo, canela casia, cromo y nopal.
Hierbas y suplementos que pueden reducir la presión arterial
El comino negro podría reducir la presión arterial. Tomarlo con otros suplementos que tienen el mismo efecto puede hacer que la presión arterial baje demasiado. Ejemplos de suplementos con este efecto incluyen andrographis, péptidos de caseína, L-arginina, niacina y ortiga.
Hierbas y suplementos que pueden retardar la coagulación sanguínea
El comino negro puede retardar la coagulación sanguínea y aumentar el riesgo de hemorragia. Tomarlo con otros suplementos con efectos similares podría aumentar el riesgo de hemorragia en algunas personas. Ejemplos de suplementos con este efecto incluyen ajo, jengibre, ginkgo, nattokinasa y Panax ginseng.
Hierro
El comino negro puede aumentar la cantidad de hierro que absorbe el cuerpo. La ingesta de comino negro junto con suplementos de hierro podría aumentar los efectos y los efectos secundarios del hierro.

¿Existen interacciones con alimentos?

No se conoce ninguna interacción con alimentos.

¿Como se usa normalmente?

Los adultos han utilizado con mayor frecuencia el aceite de comino negro en dosis de 1 a 2.5 gramos por vía oral al día durante 4 a 12 semanas. El polvo de comino negro se ha utilizado con mayor frecuencia en dosis de 1 a 2 gramos por vía oral al día durante 8 a 12 semanas. Hable con un proveedor de atención médica para averiguar qué dosis podría ser la mejor para una condición específica.

Otros nombres

Ajenuz, Aranuel, Baraka, Black Caraway, Black Cumin, Black Cumin Seed Oil, Charnuska, Cheveux de Vénus, Cominho Negro, Comino Negro, Cumin Noir, Cyah Dane, Fennel Flower, Fitch, Graine de Nigelle, Graine Noire, Habatul Sauda, Habbatul Baraka, Kalajaji, Kalajira, Kalonji, Ketsah, La Grainer Noire, Love in a Mist, Mugrela, Nielle, Nigella sativa, Nigelle de Crête, Nigelle Cultivée, Nutmeg Flower, Poivrette, Roman-Coriander, Schwarzkummel, Seed of Blessing, Siyah Dane, Shoniz, Small Fennel, Toute Épice, Upakuncika.

Metodología

Para saber más sobre cómo este artículo fue escrito, refiérase a la metodología de la Base exhaustiva de datos de medicamentos naturales.

Referencias

  1. Pipalia PR, Annigeri RG, Mehta R. Clinicobiochemical evaluation of turmeric with black pepper and nigella sativa in management of oral submucous fibrosis-a double-blind, randomized preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;122:705-712. View abstract.
  2. Pakfetrat A, Delavarian Z, Malakooti M, et al. Comparing the efficacy of a novel mucoadhesive patch containing Nigella sativa 10% with triamcinolone 0.1% in patients with erosive-atrophic oral lichen planus: A pilot study. Clin Exp Dent Res 2024;10:e886. View abstract.
  3. Mahmoudian A, Ashouri A, Bilandi RR, Mohammadzadeh F, Dashti S, Bahri N. The possible short-term of Nigella sativa - L in the management of adolescent polycystic ovarian syndrome: results of a randomized controlled trial. J Ovarian Res 2024;17:144. View abstract.
  4. Rounagh M, Musazadeh V, Hosseininejad-Mohebati A, et al. Effects of Nigella sativa supplementation on lipid profiles in adults: An updated systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN 2024;61:168-180. View abstract.
  5. Sener K, Cakir A, Yesiloglu O, Altug E, Guven R, Korkut S. Rhabdomyolysis and acute kidney injury after consumption of black seed oil. Toxicon 2024;245:107787. View abstract.
  6. Abutaima R, Al-Ebini Y, Alkofahi A, et al. In vivo assessment of black seed oil single dose on prednisolone pharmacokinetics. J Pharm Pharmacol 2024;76:57-63. View abstract.
  7. Motesadi Zarandi M, Rabbani Z, Rabbani Anari M, Kouhi A, Zeinaloo M. A study of efficacy of Nigella sativa in treatment of Meniere's disease: A randomized, placebo controlled clinical trial. J Otol 2023;18:97-100. View abstract.
  8. Mohan ME, Thomas JV, Mohan MC, Das S S, Prabhakaran P, Pulikkaparambil Sasidharan BC. A proprietary black cumin oil extract (Nigella sativa) (BlaQmax(®)) modulates stress-sleep-immunity axis safely: Randomized double-blind placebo-controlled study. Front Nutr 2023;10:1152680. View abstract.
  9. Kow CS, Ramachandram DS, Hasan SS. The effect of Nigella sativa on the risk of mortality in patients with COVID-19: A systematic review and meta-analysis of randomized trials. Phytother Res 2023. View abstract.
  10. Kavyani Z, Musazadeh V, Safaei E, et al. Antihypertensive effects of Nigella sativa supplementation: An updated systematic review and meta-analysis of randomized controlled trials. Phytother Res 2023. View abstract.
  11. Kavyani Z, Musazadeh V, Golpour-Hamedani S, Moridpour AH, Vajdi M, Askari G. The effect of Nigella sativa (black seed) on biomarkers of inflammation and oxidative stress: an updated systematic review and meta-analysis of randomized controlled trials. Inflammopharmacology 2023;31:1149-1165. View abstract.
  12. Assaad-Khalil S, Elkafrawy N, Khaled M, et al. A Phase II, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus. Evid Based Complement Alternat Med 2022;2022:9176026. View abstract.
  13. Chattopadhyay K, Wang H, Kaur J, et al. Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis. Front Pharmacol. 2022;13:821810. Published 2022 Jun 8. View abstract.
  14. Alkharfy KM, Al-Jenoobi FI, Al-Mohizea AM, et al. Effects of Lepidium sativum, Nigella sativa and Trigonella foenum-graceum on phenytoin pharmacokinetics in beagle dogs. Phytother Res. 2013;27:1800-4. View abstract.
  15. Al-Mohizea AM, Ahad A, El-Maghraby GM, et al. Effects of Nigella sativa, Lepidium sativum and Trigonella foenum-graecum on sildenafil disposition in beagle dogs. Eur J Drug Metab Pharmacokinet. 2015;40:219-24. View abstract.
  16. Rashidmayvan M, Mohammadshahi M, Seyedian SS, Haghighizadeh MH. The effect of Nigella sativa oil on serum levels of inflammatory markers, liver enzymes, lipid profile, insulin and fasting blood sugar in patients with non-alcoholic fatty liver. J Diabetes Metab Disord. 2019;18:453-459. View abstract.
  17. Wang Z, Wang X, Wang Z, et al. Potential herb-drug interaction risk of thymoquinone and phenytoin. Chem Biol Interact. 2022;353:109801. View abstract.
  18. Wang Z, Wang Z, Wang X, et al. Potential food-drug interaction risk of thymoquinone with warfarin. Chem Biol Interact. 2022;365:110070. View abstract.
  19. Sepulveda DE, Morris DP, Raup-Konsavage WM, Sun D, Vrana KE, Graziane NM. Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy. Eur J Pain 2022;26:1950-1966. View abstract.
  20. Fargeas M, Calugareanu A, Ben-Said B. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after topical use of Nigella sativa (black cumin) oil. Contact Dermatitis 2022;87:203-204. View abstract.
  21. Tavakoli-Rouzbehani OM, Abbasnezhad M, Kheirouri S, Alizadeh M. Effects of Nigella sativa oil supplementation on selected metabolic parameters and anthropometric indices in patients with coronary artery disease: A randomized, double-blind, placebo-controlled clinical trial. Phytother Res 2021;35:3988-3999. View abstract.
  22. Mostafa TM, Hegazy SK, Elnaidany SS, Shehabeldin WA, Sawan ES. Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: A comparative study of Nigella sativa versus both lifestyle modification and metformin. J Diabetes Complications 2021;35:107947. View abstract.
  23. Rashidmayvan M, Vandyousefi S, Barati M, et al. The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial. Complement Ther Clin Pract 2022;48:101598. View abstract.
  24. Montazeri RS, Fatahi S, Sohouli MH, et al. The effect of nigella sativa on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. J Food Biochem 2021;45:e13625. View abstract.
  25. Malekian S, Ghassab-Abdollahi N, Mirghafourvand M, Farshbaf-Khalili A. The effect of Nigella sativa on oxidative stress and inflammatory biomarkers: a systematic review and meta-analysis. J Complement Integr Med 2021;18:235-259. View abstract.
  26. Bin Abdulrahman KA, Bamosa AO, Bukhari AI, et al. The effect of short treatment with Nigella sativa on symptoms, the cluster of differentiation (CD) profile, and inflammatory markers in mild COVID-19 patients: A randomized, double-blind controlled trial. Int J Environ Res Public Health 2022;19:11798. View abstract.
  27. Ali SM, Chen P, Sheikh S, et al. Thymoquinone with metformin decreases fasting, post prandial glucose, and HbA1c in type 2 diabetic patients. Drug Res (Stuttg) 2021;71:302-306. View abstract.
  28. Hadi S, Daryabeygi-Khotbehsara R, Mirmiran P, et al. Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial. Phytother Res 2021;35:3747-3755. View abstract.
  29. Hussain M, Tunio AG, Akhtar L, Shaikh GS. Effects of nigella sativa on various parameters in Patients of non-alcoholic fatty liver disease. J Ayub Med Coll Abbottabad. 2017;29:403-407. View abstract.
  30. Koshak AE, Koshak EA, Mobeireek AF, et al. Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial. Complement Ther Med 2021;61:102769. View abstract.
  31. Assier H, Kouby F, Ingen-Housz-Oro S, Roux C. Severe allergic contact connubial dermatitis to Nigella Sativa Seed Oil due to repeated contacts to beard cosmetics. Contact Dermatitis 2022. View abstract.
  32. Said SA, Abdulbaset A, El-Kholy AA, Besckales O, Sabri NA. The effect of Ni gella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial. Front Pharmacol 2022;13:1011522. View abstract.
  33. Thomas JV, Mohan ME, Prabhakaran P, Das S S, Maliakel B, I M K. A phase I clinical trial to evaluate the safety of thymoquinone-rich black cumin oil (BlaQmax®) on healthy subjects: Randomized, double-blinded, placebo-controlled prospective study. Toxicol Rep 2022;9:999-1007. View abstract.
  34. Kumar S L, Naik Z, Panwar A, M S, Keluskar V, Kumar RS. Comparative evaluation of the efficacy of Nigella sativa (75% v/v) cream and clobetasol propionate (0.05% w/w) gel in oral lichen planus-a double-blinded randomized control trial. Oral Maxillofac Surg 2022. View abstract.
  35. Alizadeh A, Mohammah-Alizadeh-Charandabi S, Khodaie L, Mirghafourvand M. Effect of Nigella sativa L. seed oil on urinary incontinence and quality of life in menopausal women: A triple-blind randomized controlled trial. Phytother Res 2023. View abstract.
  36. Ashraf S, Ashraf S, Ashraf M, et al. Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multicenter placebo-controlled randomized clinical trial. Phytother Res 2022. View abstract.
  37. Bin Jardan YA, Ahad A, Raish M, Alam MA, Al-Mohizea AM, Al-Jenoobi FI. Effects of garden cress, fenugreek and black seed on the pharmacodynamics of metoprolol: an herb-drug interaction study in rats with hypertension. Pharm Biol 2021;59:1088-1097. View abstract.
  38. Alkharfy K, Jan B, Alotaibi K, et al. Clopidogrel-herb Interactions: A Pharmacokinetic and Pharmacodynamic Assessment in a Rat Model. Curr Drug Metab 2021;22:969-977. View abstract.
  39. Mohtashami A, Mahaki B, Azadbakht L, Entezari MH. Effects of bread with Nigella sativa on lipid profiles, apolipoproteins and inflammatory factor in metabolic syndrome patients. Clin Nutr Res. 2016;5:89-95. View abstract.
  40. Razmpoosh E, Safi S, Nadjarzadeh A, et al. The effect of Nigella sativa supplementation on cardiovascular risk factors in obese and overweight women: a crossover, double-blind, placebo-controlled randomized clinical trial. Eur J Nutr. 2020. View abstract.
  41. Wang X, Jiang A, Batra V. Severe thrombocytopenia associated with black seed oil and evening primrose oil. Cureus. 2020;12:e8390. View abstract.
  42. Singh V, Gupta A, Verma UP, Mishra T, Pal M. An evaluation of the efficacy of ethanolic extract of Nigella sativa L. (Kalonji) on the clinical parameters of moderate to severe gingivitis: A split mouth clinical study. Ayu. 2019;40:152-158. View abstract.
  43. Al-Azzawi MA, AboZaid MMN, Ibrahem RAL, Sakr MA. Therapeutic effects of black seed oil supplementation on chronic obstructive pulmonary disease patients: A randomized controlled double blind clinical trial. Heliyon. 2020;6:e04711. View abstract.
  44. Samadipour E, Rakhshani MH, Kooshki A, Amin B. Local usage of Nigella sativa oil as an innovative method to attenuate primary dysmenorrhea: A randomized double-blind clinical trial. Oman Med J. 2020;35:e167. View abstract.
  45. Safi S, Razmpoosh E, Fallahzadeh H, et al. The effect of Nigella sativa on appetite, anthropometric and body composition indices among overweight and obese women: A crossover, double-blind, placebo-controlled, randomized clinical trial. Complement Ther Med. 2020;57:102653. View abstract.
  46. Sarac G, Kapicioglu Y, Sener S, et al. Effectiveness of topical Nigella sativa for vitiligo treatment. Dermatol Ther 2019;32:e12949. View abstract.
  47. Tavakoly R, Arab A, Vallianou N, et al. The effect of Nigella sativa L. supplementation on serum C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 2019;45:149-55. View abstract.
  48. Moustafa HAM, El Wakeel LM, Halawa MR, Sabri NA, El-Bahy AZ, Singab AN. Effect of Nigella sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients. Endocrine 2019;65:286-94. View abstract.
  49. Darand M, Darabi Z, Yari Z, et al. The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res 2019;33:2369-77. View abstract.
  50. Behnamfar N, Parsa Yekta Z, Mojab F, Kazem Naeini SM. The effect of nigella sativa oil on the prevention of phlebitis induced by chemotherapy: a clinical trial. Biomedicine (Taipei) 2019;9:20. Erratum in: Biomedicine (Taipei) 2019;9:30. View abstract.
  51. Alam MA, Bin Jardan YA, Raish M, Al-Mohizea AM, Ahad A, Al-Jenoobi FBI. Effect of Nigella sativa and fenugreek on the pharmacokinetics and pharmacodynamics of amlodipine in hypertensive rats. Curr Drug Metab. 2020;21:318-325. View abstract.
  52. Warner ME, Warner PA, Sprung J, Warner MA. Black seed oil and perioperative serotonin syndrome: A case report. A A Pract. 2019;13:420-422. View abstract.
  53. Rafati M, Ghasemi A, Saeedi M, et al. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial. Complement Ther Med. 2019;47:102205. View abstract.
  54. He T, Xu X. The influence of Nigella sativa for asthma control: A meta-analysis. Am J Emerg Med. 2020;38:589-593. View abstract.
  55. Alizadeh-Naini M, Yousefnejad H, Hejazi N. The beneficial health effects of Nigella sativa on Helicobacter pylori eradication, dyspepsia symptoms, and quality of life in infected patients: A pilot study. Phytother Res. 2020;34:1367-1376. View abstract.
  56. Hagag AA, Badraia IM, El-Shehaby WA, Mabrouk MM. Protective role of black seed oil in doxorubicin-induced cardiac toxicity in children with acute lymphoblastic leukemia. J Oncol Pharm Pract. 2020;26:1397-1406. View abstract.
  57. Razmpoosh E, Safi S, Abdollahi N, et al. The effect of Nigella sativa on the measures of liver and kidney parameters: A systematic review and meta-analysis of randomized-controlled trials. Pharmacol Res. 2020;156:104767. View abstract.
  58. Kooshki A, Tofighiyan T, Rastgoo N, Rakhshani MH, Miri M. Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus. Phytother Res. 2020. View abstract.
  59. Soleymani S, Zargaran A, Farzaei MH, et al. The effect of a hydrogel made by Nigella sativa L. on acne vulgaris: A randomized double-blind clinical trial. Phytother Res. 2020. View abstract.
  60. Alam MA, Nasiruddin M, Haque SF, Khan RA. Evaluation of safety and efficacy profile of Nigella sativa oil as an add-on therapy, in addition to alpha-keto analogue of essential amino acids in patients with chronic kidney disease. Saudi J Kidney Dis Transpl. 2020;31:21-31. View abstract.
  61. Shirazi M, Khodakarami F, Feizabad E, Ghaemi M. The effects of nigella sativa on anthropometric and biochemical indices in postmenopausal women with metabolic syndrome. Endocrine. 2020;69:49-52. View abstract.
  62. Amizadeh S, Rashtchizadeh N, Khabbazi A, et al. Effect of Nigella sativa oil extracts on inflammatory and oxidative stress markers in Behcet's disease: A randomized, double-blind, placebo-controlled clinical trial. Avicenna J Phytomed. 2020;10:181-189. View abstract.
  63. Ardiana M, Pikir BS, Santoso A, Hermawan HO, Al-Farabi MJ. Effect of Nigella sativa supplementation on oxidative stress and antioxidant parameters: A meta-analysis of randomized controlled trials. ScientificWorldJournal. 2020;2020:2390706. View abstract.
  64. Busari AA, Adejare AA, Shodipe AF, Oduniyi OA, Ismail-Badmus KB, Oreagba IA. Protective but Non-Synergistic Effects of Nigella Sativa and Vitamin E against Cisplatin-Induced Renal Toxicity and Oxidative Stress in Wistar Rats. Drug Res (Stuttg). 2018 Dec;68:696-703. View abstract.
  65. Molaie M, Darvishi B, Jafari Azar Z, Shirazi M, Amin G, Afshar S. Effects of a combination of Nigella sativa and Vitex agnus-castus with citalopram on healthy menopausal women with hot flashes: results from a subpopulation analysis. Gynecol Endocrinol. 2019 Jan;35:58-61. View abstract.
  66. Dehavay F, Kolivras A, Scheers C. Local and systemic adverse skin reactions following the use of herbal products believed to contain Nigella sativa seeds and oil. Contact Dermatitis. 2019 Mar;80:176-177. View abstract.
  67. Nikkhah-Bodaghi M, Darabi Z, Agah S, Hekmatdoost A. The effects of Nigella sativa on quality of life, disease activity index, and some of inflammatory and oxidative stress factors in patients with ulcerative colitis. Phytother Res. 2019 Apr;33:1027-1032. doi: 10.1002/ptr.6296. Epub 2019 Jan 22. View abstract.
  68. Khonche A, Huseini HF, Gholamian M, Mohtashami R, Nabati F, Kianbakht S. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial. J Ethnopharmacol. 2019 Apr 24;234:106-111. View abstract.
  69. Namazi N, Larijani B, Ayati MH, Abdollahi M. The effects of Nigella sativa L. on obesity: a systematic review and meta-analysis. J Ethnopharmacol 2018;219:173-81. doi: 10.1016/j.jep.2018.03.001. View abstract.
  70. Tuna HI, Babadag B, Ozkaraman A, Balci Alparslan G. Investigation of the effect of black cumin oil on pain in osteoarthritis geriatric individuals. Complement Ther Clin Pract 2018;31:290-4. doi: 10.1016/j.ctcp.2018.03.013. View abstract.
  71. Mousa HFM, Abd-El-Fatah NK, Darwish OA, Shehata SF, Fadel SH. Effect of Nigella sativa seed administration on prevention of febrile neutropenia during chemotherapy among children with brain tumors. Childs Nerv Syst. 2017;33:793-800. View abstract.
  72. Fallah Huseini H, Amini M, Mohtashami R, et al. Blood pressure lowering effect of Nigella sativa L. seed oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res. 2013;27:1849-53. View abstract.
  73. Bin Sayeed MS, Asaduzzaman M, Morshed H, Hossain MM, Kadir MF, Rahman MR. The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteers. J Ethnopharmacol. 2013;148:780-6. View abstract.
  74. Mahdavi R, Namazi N, Alizadeh M, Farajnia S. Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial. Food Funct. 2015;6:2041-8. View abstract.
  75. Mousavi SM, Sheikhi A, Varkaneh HK, Zarezadeh M, Rahmani J, Milajerdi A. Effect of Nigella sativa supplementation on obesity indices: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2018;38:48-57. View abstract.
  76. Dajani EZ, Shahwan TG, Dajani NE. Overview of the preclinical pharmacological properties of Nigella sativa (black seeds): a complementary drug with historical and clinical significance. J Physiol Pharmacol. 2016;67:801-817. View abstract.
  77. Onifade AA, Jewell AP, Adedeji WA. Nigella sativa concoction induced sustained seroreversion in HIV patient. Afr J Tradit Complement Altern Med. 2013;10:332-5. View abstract.
  78. Isik H, Cevikbas A, Gürer US, et al. Potential adjuvant effects of Nigella sativa seeds to improve specific immunotherapy in allergic rhinitis patients. Med Princ Pract. 2010;19:206-11. View abstract.
  79. Bin Sayeed MS, Shams T, Fahim Hossain S, et al. Nigella sativa L. seeds modulate mood, anxiety and cognition in healthy adolescent males. J Ethnopharmacol. 2014;152:156-62. View abstract.
  80. Nikakhlagh S, Rahim F, Aryani FH, Syahpoush A, Brougerdnya MG, Saki N. Herbal treatment of allergic rhinitis: the use of nigella sativa. Am J Otolaryngol. 2011 Sep-Oct;32:402-7. View abstract.
  81. Oysu C, Tosun A, Yilmaz HB, Sahin-Yilmaz A, Korkmaz D, Karaaslan A. Topical nigella sativa for nasal symptoms in elderly. Auris Nasus Larynx. 2014 Jun;41:269-72. View abstract.
  82. Koshak A, Wei L, Koshak E, et al. Nigella sativa supplementation improves asthma control and biomarkers: a randomized, double-blind, placebo-controlled trial. Phytother Res. 2017 Mar;31:403-9. View abstract.
  83. Barakat EM, El Wakeel LM, Hagag RS. Effects of nigella sativa on outcome of hepatitis C in Egypt. World J Gastroenterol. 2013 Apr 28;19:2529-36. View abstract.
  84. Ahmad Alobaidi AH. Effect of nigella sativa and allium sativum coadministered with simvastatin in dyslipidemia patients: a prospective, randomized, double-blind trial. Antiinflamm Antiallergy Agents Med Chem. 2014 Mar;13:68-74. View abstract.
  85. Hagag AA, AbdElaal AM, Elfaragy MS, Hassan SM, Elzamarany EA. Therapeutic value of black seed oil in methotrexate hepatotoxicity in Egyptian children with acute lymphoblastic leukemia. Infect Disord Drug Targets. 2015;15:64-71. View abstract.
  86. Farzaneh E, Nia FR, Mehrtash M, Mirmoeini FS, Jalilvand M. The effects of 8-week nigella sativa supplementation and aerobic training on lipid profile and VO2 max in sedentary overweight females. Int J Prev Med. 2014 Feb;5:210-16. View abstract.
  87. Muneera KE, Majeed A, Naveed AK. Comparative evaluation of nigella sativa (Kalonji) and simvastatin for the treatment of hyperlipidemia and in the induction of hepatotoxicity. Pak J Pharm Sci. 2015 Mar;28:493-8. View abstract.
  88. Kooshki A, Forouzan R, Rakhshani MH, Mohammadi M. Effect of topical application of nigella sativa oil and oral acetaminophen on pain in elderly with knee osteoarthritis: a crossover clinical trial. Electron Physician. 2016 Nov 25;8:3193-97. View abstract.
  89. Salem EM, Yar T, Bamosa AO, et al. Comparative study of nigella sativa and triple therapy in eradication of helicobacter pylori in patients with non-ulcer dyspepsia. Saudi J Gastroenterol. 2010 Jul-Sep;16:207-14. View abstract.
  90. Datau EA, Wardhana, Surachmanto EE, Pandelaki K, Langi JA, Fias. Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Med Indones. 2010;42:130-4. View abstract.
  91. Shawki M, El Wakeel L, Shatla R, et al. The clinical outcome of adjuvant therapy with black seed oil on intractable paediatric seizures: a pilot study. Epileptic Disord 2013;15:295-301. View abstract.
  92. Salem AM, Bamosa AO, Qutub HO, et al. Effect of Nigella sativa supplementation on lung function and inflammatory mediatorsin partly controlled asthma: a randomized controlled trial. Ann Saudi Med 2017;37:64-71. View abstract.
  93. Sahebkar A, Soranna D, Liu X, et al. A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure. J Hypertens 2016;34:2127-35. View abstract.
  94. Perveen T, Haider S, Zuberi NA, et al. Increased 5-HT levels following repeated administration of Nigella sativa L. (Black Seed) oil produce antidepressant effects in rats. Sci Pharm 2013;82:161-70. View abstract.
  95. Mohtashami R, Huseini HF, Heydari M, et al. Efficacy and safety of honey based formulation of Nigella sativa seed oil in functional dyspepsia: A double blind randomized controlled clinical trial. J Ethnopharmacol 2015;175:147-52. View abstract.
  96. Kolahdooz M, Nasri S, Modarres SZ, et al. Effects of Nigella sativa L. seed oil on abnormal semen quality in infertile men: a randomized, double-blind, placebo-controlled clinical trial. Phytomedicine 2014;21:901-5. View abstract.
  97. Kaatabi H, Bamosa AO, Badar A, et al. Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial. PLoS One 2015;10:e0113486. View abstract.
  98. Ibrahim RM, Hamdan NS, Mahmud R, et al. ff LA, Ismail M. A randomised controlled trial on hypolipidemic effects of Nigella Sativa seeds powder in menopausal women. J Transl Med 2014;12:82. View abstract.
  99. Huseini HF, Kianbakht S, Mirshamsi MH, Zarch AB. Effectiveness of topical Nigella sativa seed oil in the treatment of cyclic mastalgia: A randomized, triple-blind, active, and placebo-controlled clinical trial. Planta Med 2016;82:285-8. View abstract.
  100. Gheita TA, Kenawy SA. Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study. Phytother Res 2012;26:1246-8. View abstract.
  101. Farhangi MA, Dehghan P, Tajmiri S, Abbasi MM. The effects of Nigella sativa on thyroid function, serum Vascular Endothelial Growth Factor (VEGF) - 1, Nesfatin-1 and anthropometric features in patients with Hashimoto's thyroiditis: a randomized controlled trial. BMC Complement Altern Med 2016;16:471. View abstract.
  102. Bonhomme A, Poreaux C, Jouen F, et al. Bullous drug eruption to Nigella sativa oil: Consideration of the use of a herbal medicine - clinical report and review of the literature. J Eur Acad Dermatol Venereol 2017;31:e217-e219. View abstract.
  103. Bamosa AO, Kaatabi H, Lebdaa FM, et al. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian J Physiol Pharmacol 2010;54:344-54. View abstract.
  104. Badar A, Kaatabi H, Bamosa A, et al. Effect of Nigella sativa supplementation over a one-year period on lipid levels, blood pressure and heart rate in type-2 diabetic patients receiving oral hypoglycemic agents: nonrandomized clinical trial. Ann Saudi Med 2017;37:56-63. View abstract.
  105. Arslan E, Sayin S, Demirbas S, et al. A case study report of acute renal failure associated with Nigella sativa in a diabetic patient. J Integr Med 2013;11:64-6. View abstract.
  106. Al-Jenoobi FI, Al-Suwayeh SA, Muzaffar I, et al. Effects of Nigella sativa and Lepidium sativum on cyclosporine pharmacokinetics. Biomed Res Int 2013;2013:953520. View abstract.
  107. Azza, M. M. Nadia M. M. Sohair S. Sativa seeds against
  108. Boskabady MH and et al. Inhibitory effect of Nigella sativa on histamine receptors of isolated guinea pig tracheal chains. Pharmaceutical Biology (Netherlands). 2002;40:596-602.
  109. Parvardeh S and et al. Effects of thymoquinone, the major constituent of Nigella sativa seeds, on the contractile responses of rat vas deferens. Pharmaceutical Biology (Netherlands). 2003;41:616-621.
  110. Benhaddou-Andaloussi A and et al. Antidiabetic activity of Nigella sativa seed extract in cultured pancreatic beta-cells, skeletal muscle cells, and adipocytes. Pharmaceutical Biology (Netherlands) 2010;:96-104.
  111. Stern T and et al. Black seed oil ointment - A new approach for the treatment of atopic dermatitis? Aktuelle Dermatologie 2002;28:74-79.
  112. Asgari S and et al. The effects of Nigella sativa on atherosclerosis and its new risk factors in hypercholesterolemic rabbits. Iranian Journal of Diabetes & Lipid Disorders (IRANIAN J DIABETES LIPID DISORD) 2007;6:E29.
  113. Akhondian JAV and et al. A pilot study on the effects of Nigella sativa seeds aqueous extract on paediatric intractable seizures. Epilepsia 2005;46:3-415.
  114. El-Gharieb MA and et al. Potential hepatoprotective effects of vitamin E and Nigella sativa oil on hepatotoxicity induced by chronic exposure to malathion in human and male albino rats. Toxicological & Environmental Chemistry. 2010;92:395-412.
  115. Kamal EH and et al. Some cardiovascular effects of the dethymoquinonated Nigella sativa volatile oil and its major components alpha-pinene and p-cymene in rats. Saudi Pharmaceutical Journal (Saudi Arabia). 2003;11:104-110.
  116. Badary, O. A., Nagi, M. N., Al Shabanah, O. A., Al Sawaf, H. A., Al Sohaibani, M. O., and Al Bekairi, A. M. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol. 1997;75:1356-1361. View abstract.
  117. Steinmann, A., Schatzle, M., Agathos, M., and Breit, R. Allergic contact dermatitis from black cumin (Nigella sativa) oil after topical use. Contact Dermatitis 1997;36:268-269. View abstract.
  118. al Sheikh, O. A. and Gad el-Rab, M. O. Allergic contact dermatitis: clinical features and profile of sensitizing allergens in Riyadh, Saudi Arabia. Int J Dermatol. 1996;35:493-497. View abstract.
  119. el Tahir, K. E., Ashour, M. M., and al Harbi, M. M. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. Gen.Pharmacol. 1993;24:1123-1131. View abstract.
  120. Boskabady, M. H., Mohsenpoor, N., and Takaloo, L. Antiasthmatic effect of Nigella sativa in airways of asthmatic patients. Phytomedicine 2-8-2010; View abstract.
  121. Yildiz, F., Coban, S., Terzi, A., Savas, M., Bitiren, M., Celik, H., and Aksoy, N. Protective effects of Nigella sativa against ischemia-reperfusion injury of kidneys. Ren Fail. 2010;32:126-131. View abstract.
  122. Fararh, K. M., Ibrahim, A. K., and Elsonosy, Y. A. Thymoquinone enhances the activities of enzymes related to energy metabolism in peripheral leukocytes of diabetic rats. Res Vet.Sci 2010;88:400-404. View abstract.
  123. Najmi, A., Nasiruddin, M., Khan, R. A., and Haque, S. F. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int J Diabetes Dev.Ctries. 2008;28:11-14. View abstract.
  124. Al Naqeep, G., Ismail, M., and Allaudin, Z. Regulation of Low-Density Lipoprotein Receptor and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Gene Expression by Thymoquinone-Rich Fraction and Thymoquinone in HepG2 Cells. J Nutrigenet.Nutrigenomics. 10-30-2009;2(4-5):163-172. View abstract.
  125. Keyhanmanesh, R., Boskabady, M. H., Eslamizadeh, M. J., Khamneh, S., and Ebrahimi, M. A. The effect of thymoquinone, the main constituent of Nigella sativa on tracheal responsiveness and white blood cell count in lung lavage of sensitized guinea pigs. Planta Med 2010;76:218-222. View abstract.
  126. Kocyigit, Y., Atamer, Y., and Uysal, E. The effect of dietary supplementation of Nigella sativa L. on serum lipid profile in rats. Saudi Med J 2009;30:893-896. View abstract.
  127. Qidwai, W., Hamza, H. B., Qureshi, R., and Gilani, A. Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial. J Altern.Complement Med 2009;15:639-644. View abstract.
  128. Kanter, M. Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy. J Mol.Histol. 2009;40:107-115. View abstract.
  129. Landa, P., Marsik, P., Havlik, J., Kloucek, P., Vanek, T., and Kokoska, L. Evaluation of antimicrobial and anti-inflammatory activities of seed extracts from six Nigella species. J Med Food 2009;12:408-415. View abstract.
  130. Kanter, M. Effects of Nigella sativa seed extract on ameliorating lung tissue damage in rats after experimental pulmonary aspirations. Acta Histochem. 2009;111:393-403. View abstract.
  131. Sangi, S., Ahmed, S. P., Channa, M. A., Ashfaq, M., and Mastoi, S. M. A new and novel treatment of opioid dependence: Nigella sativa 500 mg. J Ayub.Med Coll.Abbottabad. 2008;20:118-124. View abstract.
  132. Perveen, T., Haider, S., Kanwal, S., and Haleem, D. J. Repeated administration of Nigella sativa decreases 5-HT turnover and produces anxiolytic effects in rats. Pak.J Pharm.Sci 2009;22:139-144. View abstract.
  133. Nagi, M. N. and Almakki, H. A. Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity. Phytother.Res 2009;23:1295-1298. View abstract.
  134. Aljabre, S. H., Randhawa, M. A., Alakloby, O. M., and Alzahrani, A. J. Thymoquinone inhibits germination of dermatophyte arthrospores. Saudi Med J 2009;30:443-445. View abstract.
  135. Boskabady, M. H., Keyhanmanesh, R., and Saadatloo, M. A. Relaxant effects of different fractions from Nigella sativa L. on guinea pig tracheal chains and its possible mechanism(s). Indian J Exp.Biol. 2008;46:805-810. View abstract.
  136. Landa, P., Kokoska, L., Pribylova, M., Vanek, T., and Marsik, P. In vitro anti-inflammatory activity of carvacrol: Inhibitory effect on COX-2 catalyzed prostaglandin E biosynthesis. Arch Pharm.Res 2009;32:75-78. View abstract.
  137. Edris, A. E. Anti-cancer properties of Nigella spp. essential oils and their major constituents, thymoquinone and beta-elemene. Curr.Clin Pharmacol. 2009;4:43-46. View abstract.
  138. Vance, S. H., Benghuzzi, H., Wilson-Simpson, F., and Tucci, M. Thymoquinone supplementation and its effect on kidney tubule epithelial cells in vitro. Biomed.Sci Instrum. 2008;44:477-482. View abstract.
  139. Meddah, B., Ducroc, R., El Abbes, Faouzi M., Eto, B., Mahraoui, L., Benhaddou-Andaloussi, A., Martineau, L. C., Cherrah, Y., and Haddad, P. S. Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J Ethnopharmacol. 1-30-2009;121:419-424. View abstract.
  140. Boskabady, M. H. and Farhadi, J. The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trial. J Altern.Complement Med 2008;14:1137-1144. View abstract.
  141. Fouda, A. M., Daba, M. H., Dahab, G. M., and Sharaf El-Din, O. A. Thymoquinone ameliorates renal oxidative damage and proliferative response induced by mercuric chloride in rats. Basic Clin Pharmacol.Toxicol. 2008;103:109-118. View abstract.
  142. Dirjomuljono, M., Kristyono, I., Tjandrawinata, R. R., and Nofiarny, D. Symptomatic treatment of acute tonsillo-pharyngitis patients with a combination of Nigella sativa and Phyllanthus niruri extract. Int J Clin Pharmacol.Ther 2008;46:295-306. View abstract.
  143. El Wakil, S. S. Evaluation of the in vitro effect of Nigella sativa aqueous extract on Blastocystis hominis isolates. J Egypt Soc.Parasitol. 2007;37:801-813. View abstract.
  144. Bayrak, O., Bavbek, N., Karatas, O. F., Bayrak, R., Catal, F., Cimentepe, E., Akbas, A., Yildirim, E., Unal, D., and Akcay, A. Nigella sativa protects against ischaemia/reperfusion injury in rat kidneys. Nephrol.Dial.Transplant. 2008;23:2206-2212. View abstract.
  145. Akhondian, J., Parsa, A., and Rakhshande, H. The effect of Nigella sativa L. (black cumin seed) on intractable pediatric seizures. Med Sci Monit. 2007;13:CR555-CR559. View abstract.
  146. Singh, B. B., Khorsan, R., Vinjamury, S. P., Der-Martirosian, C., Kizhakkeveettil, A., and Anderson, T. M. Herbal treatments of asthma: a systematic review. J Asthma 2007;44:685-698. View abstract.
  147. Ayaz, E., Yilmaz, H., Ozbek, H., Tas, Z., and Orunc, O. The effect of Nigella sativa oil against Aspiculuris tetraptera and Hymenolepis nana in naturally infected mice. Saudi Med J 2007;28:1654-1657. View abstract.
  148. Boskabady, M. H., Javan, H., Sajady, M., and Rakhshandeh, H. The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients. Fundam.Clin Pharmacol. 2007;21:559-566. View abstract.
  149. Kanter, M. Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem.Res 2008;33:87-96. View abstract.
  150. El Gazzar, M. A. Thymoquinone suppressses in vitro production of IL-5 and IL-13 by mast cells in response to lipopolysaccharide stimulation. Inflamm.Res 2007;56:345-351. View abstract.
  151. Massadeh, A. M., Al Safi, S. A., Momani, I. F., Al Mahmoud, M., and Alkofahi, A. S. Analysis of cadmium and lead in mice organs: effect of Nigella sativa L. (Black Cumin) on the distribution and immunosuppressive effect of cadmium-lead mixture in mice. Biol.Trace Elem.Res 2007;115:157-167. View abstract.
  152. Hawsawi, Z. A., Ali, B. A., and Bamosa, A. O. Effect of Nigella sativa (Black Seed) and thymoquinone on blood glucose in albino rats. Ann.Saudi Med 2001;21(3-4):242-244. View abstract.
  153. Kaleem, M., Kirmani, D., Asif, M., Ahmed, Q., and Bano, B. Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian J Exp.Biol. 2006;44:745-748. View abstract.
  154. Abbas, A. T., Abdel-Aziz, M. M., Zalata, K. R., and Tel, Abd Al-Galel. Effect of dexamethasone and Nigella sativa on peripheral blood eosinophil count, IgG1 and IgG2a, cytokine profiles and lung inflammation in murine model of allergic asthma. Egypt J Immunol. 2005;12:95-102. View abstract.
  155. El Obeid, A., Al Harbi, S., Al Jomah, N., and Hassib, A. Herbal melanin modulates tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) production. Phytomedicine. 2006;13:324-333. View abstract.
  156. Kanter, M., Demir, H., Karakaya, C., and Ozbek, H. Gastroprotective activity of Nigella sativa L oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. World J Gastroenterol. 11-14-2005;11:6662-6666. View abstract.
  157. Islam, S. K., Ahsan, M., Hassan, C. M., and Malek, M. A. Antifungal activities of the oils of Nigella sativa seeds. Pak.J Pharm.Sci 1989;2:25-28. View abstract.
  158. Ghannadi, A., Hajhashemi, V., and Jafarabadi, H. An investigation of the analgesic and anti-inflammatory effects of Nigella sativa seed polyphenols. J Med Food 2005;8:488-493. View abstract.
  159. Gali-Muhtasib, H., Roessner, A., and Schneider-Stock, R. Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol. 2006;38:1249-1253. View abstract.
  160. Kanter, M., Coskun, O., and Uysal, H. The antioxidative and antihistaminic effect of Nigella sativa and its major constituent, thymoquinone on ethanol-induced gastric mucosal damage. Arch Toxicol. 2006;80:217-224. View abstract.
  161. Marsik, P., Kokoska, L., Landa, P., Nepovim, A., Soudek, P., and Vanek, T. In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses. Planta Med 2005;71:739-742. View abstract.
  162. Dahri, A. H., Chandiol, A. M., Rahoo, A. A., and Memon, R. A. Effect of Nigella sativa (kalonji) on serum cholesterol of albino rats. J Ayub.Med Coll.Abbottabad. 2005;17:72-74. View abstract.
  163. Fararh, K. M., Shimizu, Y., Shiina, T., Nikami, H., Ghanem, M. M., and Takewaki, T. Thymoquinone reduces hepatic glucose production in diabetic hamsters. Res Vet.Sci 2005;79:219-223. View abstract.
  164. Ilhan, A., Gurel, A., Armutcu, F., Kamisli, S., and Iraz, M. Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice. Neuropharmacology 2005;49:456-464. View abstract.
  165. El Mahmoudy, A., Shimizu, Y., Shiina, T., Matsuyama, H., Nikami, H., and Takewaki, T. Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone. Acta Diabetol. 2005;42:23-30. View abstract.
  166. Awad, E. M. and Binder, B. R. In vitro induction of endothelial cell fibrinolytic alterations by Nigella sativa. Phytomedicine 2005;12:194-202. View abstract.
  167. Toama, M. A., El Alfy, T. S., and El Fatatry, H. M. Antimicrobial activity of the volatile oil of Nigella sativa Linneaus seeds. Antimicrob.Agents Chemother. 1974;6:225-226. View abstract.
  168. Hosseinzadeh, H., Parvardeh, S., Nassiri-Asl, M., and Mansouri, M. T. Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. Med Sci Monit. 2005;11:BR106-BR110. View abstract.
  169. Mansour, M. and Tornhamre, S. Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. J Enzyme Inhib.Med Chem. 2004;19:431-436. View abstract.
  170. Gali-Muhtasib, H., Diab-Assaf, M., Boltze, C., Al Hmaira, J., Hartig, R., Roessner, A., and Schneider-Stock, R. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol. 2004;25:857-866. View abstract.
  171. Le, P. M., Benhaddou-Andaloussi, A., Elimadi, A., Settaf, A., Cherrah, Y., and Haddad, P. S. The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J Ethnopharmacol. 2004;94(2-3):251-259. View abstract.
  172. Kanter, M., Coskun, O., Korkmaz, A., and Oter, S. Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocin-induced diabetic rats. Anat.Rec.A Discov.Mol.Cell Evol.Biol. 2004;279:685-691. View abstract.
  173. Fararh, K. M., Atoji, Y., Shimizu, Y., Shiina, T., Nikami, H., and Takewaki, T. Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Res Vet.Sci 2004;77:123-129. View abstract.
  174. Islam, S. N., Begum, P., Ahsan, T., Huque, S., and Ahsan, M. Immunosuppressive and cytotoxic properties of Nigella sativa. Phytother.Res. 2004;18:395-398. View abstract.
  175. Ali, B. H. The effect of Nigella sativa oil on gentamicin nephrotoxicity in rats. Am.J Chin Med 2004;32:49-55. View abstract.
  176. Hosseinzadeh, H. and Parvardeh, S. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine 2004;11:56-64. View abstract.
  177. El Saleh, S. C., Al Sagair, O. A., and Al Khalaf, M. I. Thymoquinone and Nigella sativa oil protection against methionine-induced hyperhomocysteinemia in rats. Int J Cardiol. 2004;93:19-23. View abstract.
  178. Kanter, M., Meral, I., Yener, Z., Ozbek, H., and Demir, H. Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku J Exp.Med 2003;201:213-219. View abstract.
  179. Kalus, U., Pruss, A., Bystron, J., Jurecka, M., Smekalova, A., Lichius, J. J., and Kiesewetter, H. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother.Res. 2003;17:1209-1214. View abstract.
  180. Al Naggar, T. B., Gomez-Serranillos, M. P., Carretero, M. E., and Villar, A. M. Neuropharmacological activity of Nigella sativa L. extracts. J Ethnopharmacol. 2003;88:63-68. View abstract.
  181. Al Majed, A. A., Daba, M. H., Asiri, Y. A., Al Shabanah, O. A., Mostafa, A. A., and El Kashef, H. A. Thymoquinone-induced relaxation of guinea-pig isolated trachea. Res Commun.Mol.Pathol.Pharmacol. 2001;110(5-6):333-345. View abstract.
  182. Hansen, J. T., Benghuzzi, H., Tucci, M., and Cason, Z. The role of black seed in the proliferation and biochemical marker levels of Hep-2 cells. Biomed.Sci.Instrum. 2003;39:371-376. View abstract.
  183. Ali, B. H. and Blunden, G. Pharmacological and toxicological properties of Nigella sativa. Phytother.Res. 2003;17:299-305. View abstract.
  184. Al Jishi, S. A. and Abuo, Hozaifa B. Effect of Nigella sativa on blood hemostatic function in rats. J Ethnopharmacol. 2003;85:7-14. View abstract.
  185. Bamosa, A. O., Ali, B. A., and al Hawsawi, Z. A. The effect of thymoquinone on blood lipids in rats. Indian J Physiol Pharmacol. 2002;46:195-201. View abstract.
  186. Shoieb, A. M., Elgayyar, M., Dudrick, P. S., Bell, J. L., and Tithof, P. K. In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol. 2003;22:107-113. View abstract.
  187. el Dakhakhny, M., Mady, N., Lembert, N., and Ammon, H. P. The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Med 2002;68:465-466. View abstract.
  188. Meral, I., Yener, Z., Kahraman, T., and Mert, N. Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defence system and liver damage in experimentally-induced diabetic rabbits. J Vet.Med A Physiol Pathol.Clin Med 2001;48:593-599. View abstract.
  189. Al Ghamdi, M. S. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol. 2001;76:45-48. View abstract.
  190. Kumara, S. S. and Huat, B. T. Extraction, isolation and characterisation of antitumor principle, alpha-hederin, from the seeds of Nigella sativa. Planta Med 2001;67:29-32. View abstract.
  191. Enomoto, S., Asano, R., Iwahori, Y., Narui, T., Okada, Y., Singab, A. N., and Okuyama, T. Hematological studies on black cumin oil from the seeds of Nigella sativa L. Biol.Pharm.Bull 2001;24:307-310. View abstract.
  192. el Dakhakhny, M., Mady, N. I., and Halim, M. A. Nigella sativa L. oil protects against induced hepatotoxicity and improves serum lipid profile in rats. Arzneimittelforschung. 2000;50:832-836. View abstract.
  193. Zaoui, A., Cherrah, Y., Lacaille-Dubois, M. A., Settaf, A., Amarouch, H., and Hassar, M. [Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat]. Therapie 2000;55:379-382. View abstract.
  194. Abdel-Fattah, A. M., Matsumoto, K., and Watanabe, H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur.J Pharmacol. 7-14-2000;400:89-97. View abstract.
  195. Jadayil, S. A., Tukan, S. K., and Takruri, H. R. Bioavailability of iron from four different local food plants in Jordan. Plant Foods Hum.Nutr. 1999;54:285-294. View abstract.
  196. Badary, O. A., Abdel-Naim, A. B., Abdel-Wahab, M. H., and Hamada, F. M. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicology 3-7-2000;143:219-226. View abstract.
  197. Badary, O. A. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J Ethnopharmacol. 11-1-1999;67:135-142. View abstract.
  198. Reiter, M. and Brandt, W. Relaxant effects on tracheal and ileal smooth muscles of the guinea pig. Arzneimittelforschung. 1985;35(1A):408-414. View abstract.
  199. Haqqaq EG, Abou-Moustafa MA, Boucher W, Theoharides TC. The effect of a herbal water-extract on histamine release from mast cells and on allergic asthma. J Herb Pharmacother 2003;3:41-54. View abstract.
  200. Sabzghabaee AM, Dianatkhah M, Sarrafzadegan N, et al. Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial. Medicinski Arhiv 2012;66:198-200. View abstract.
  201. Dehkordi FR, Kamkhah AF. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam Clin Pharmacol 2008;22:447-52. View abstract.
  202. Akhtar MS, Riffat S. Field trial of Saussurea lappa roots against nematodes and Nigella sativa seeds against cestodes in children. J Pak Med Assoc 1991;41:185-7. View abstract.
  203. Medenica RD. Use of Black seed to increase immune function. U.S. Patent 5,482,711, issued January 9, 1996. Obtained from US Patent and Trademark Ofc on April 12, 2000. www.uspto.gov/patft/index.htm.
  204. Tennekoon KH, Jeevathayaparan S, Kurukulasooriya AP, Karunanayake EH. Possible hepatotoxicity of Nigella sativa seeds and Dregea volubilis leaves. J Ethnopharmacol 1991;31:283-9. View abstract.
  205. Hanafy MS, Hatem ME. Studies on the antimicrobial activity of Black seed seed (black cumin). J Ethnopharmacol 1991;34:275-8. View abstract.
  206. Keshri G, Singh MM, Lakshmi V, Kamboj VP. Post-coital contraceptive efficacy of the seeds of Black seed in rats. Indian J Physiol Pharmacol 1995;39:59-62. View abstract.
  207. Aqel M, Shaheen R. Effects of the volatile oil of black seed seeds on the uterine smooth muscle of rat and guinea pig. J Ethnopharmacol 1996;52:23-6. View abstract.
  208. Nagi MN, Alam K, Badary OA, et al. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int 1999;47:153-9. View abstract.
  209. Badary OA, Al-Shabanah OA, Nagi MN, et al. Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone. Eur J Cancer Prev 1999;8:435-40. View abstract.
  210. Worthen DR, Ghosheh OA, Crooks PA. The in vitro anti-tumor activity of some crude and purified components of blackseed, Black seed L. Anticancer Res 1998;18(3A):1527-32. View abstract.
  211. Daba MH, Abdel-Rahman MS. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol Lett 1998;95:23-9. View abstract.
  212. Salomi NJ, Nair SC, Jayawardhanan KK, et al. Antitumour principles from Black seed seeds. Cancer Lett 1992;63:41-6. View abstract.
  213. Houghton PJ, Zarka R, de las Heras B, Hoult JR. Fixed oil of Black seed and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995;61:33-6. View abstract.
  214. Haq A, Abdullatif M, Lobo PI, et al. Black seed: effect on human lymphocytes and polymorphonuclear leukocyte phagocytic activity. Immunopharmacology 1995;30:147-55. View abstract.
  215. Chakravarty N. Inhibition of histamine release from mast cells by nigellone. Ann Allergy 1993;70:237-42. View abstract.
  216. The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.
Documento revisado - 11/11/2024